|
Myasthenia
Citations 21-30 of 67 total displayed.
|
Past content
(since Jan 2001):
|
- BRIEF COMMUNICATIONS
Occurrence of CNS demyelinating disease in patients with myasthenia gravis
- Marc Gotkine, Yakov Fellig, and Oded Abramsky
Neurology 2006; 67: 881-883.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Anti-MuSK antibodies: Correlation with myasthenia gravis severity
- E. Bartoccioni, F. Scuderi, G. M. Minicuci, M. Marino, F. Ciaraffa, and A. Evoli
Neurology 2006; 67: 505-507.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Strong association of MuSK antibody–positive myasthenia gravis and HLA-DR14-DQ5
- E. H. Niks, J.B.M. Kuks, B. O. Roep, G. W. Haasnoot, W. Verduijn, B. E.P.B. Ballieux, M. H. De Baets, A. Vincent, and J. J.G.M. Verschuuren
Neurology 2006; 66: 1772-1774.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Novel congenital myasthenic syndromes associated with defects in quantal release
- M. Milone, T. Fukuda, X. M. Shen, A. Tsujino, J. Brengman, and A. G. Engel
Neurology 2006; 66: 1223-1229.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
MuSK Ab described in seropositive MG sera found to be Ab to alkaline phosphatase
- K. Ohta, K. Shigemoto, S. Kubo, N. Maruyama, Y. Abe, N. Ueda, A. Fujinami, and M. Ohta
Neurology 2005; 65: 1988.
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil
- Steven Vernino, Diva R. Salomao, Thomas M. Habermann, and Brian P. O’Neill
Neurology 2005; 65: 639-641.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
An intronic base alteration of the CHRNE gene leading to a congenital myasthenic syndrome
- J. S. Müller, R. Stucka, S. Neudecker, S. Zierz, C. Schmidt, A. Huebner, H. Lochmüller, and A. Abicht
Neurology 2005; 65: 463-465.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Congenital endplate acetylcholinesterase deficiency responsive to ephedrine
- M. Bestue-Cardiel, A. Sáenz de Cabezón-Alvarez, J. L. Capablo-Liesa, J. López-Pisón, J. L. Peña-Segura, J. Martin-Martinez, and A. G. Engel
Neurology 2005; 65: 144-146.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Treatment with botulinum toxin in a patient with myasthenia gravis and cervical dystonia
- A. Fasano, A. R. Bentivoglio, T. Ialongo, F. Soleti, and A. Evoli
Neurology 2005; 64: 2155-2156.
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Quantitative myasthenia gravis score: Assessment of responsiveness and longitudinal validity
- R. S. Bedlack, D. L. Simel, H. Bosworth, G. Samsa, B. Tucker-Lipscomb, and D. B. Sanders
Neurology 2005; 64: 1968-1970.
[Abstract]
[Full text]
[PDF]
|
|
